A Multi-Factorial Observational Study on Sequential Fecal Microbiota Transplant in Patients with Medically Refractory Clostridioides difficile Infection
Authors:
- Tanya M. MonaghanTMTanya M. Monaghan
- Niharika A. DuggalNDNiharika A. Duggal
- Elisa RosatiERElisa Rosati
- Ruth GriffinRuth Griffin
- Jamie HughesJHJamie Hughes
- Brandi RoachBRBrandi Roach
- David Y. YangDYDavid Y. Yang
- Christopher WangCWChristopher Wang
- Karen WongKWKaren Wong
- Lynora SaxingerLSLynora Saxinger
- Maja Pučić-BakovićMPMaja Pučić-Baković
- Frano VučkovićFVFrano Vučković
Open Access
Abstract
Fecal microbiota transplantation (FMT) is highly effective in recurrent Clostridioides difficile infection (CDI); increasing evidence supports FMT in severe or fulminant Clostridioides difficile infection (SFCDI). However, the multifactorial mechanisms that underpin the efficacy of FMT are not fully understood. Systems biology approaches using high-throughput technologies may help with mechanistic dissection of host-microbial interactions. Here, we have undertaken a deep phenomics study on four adults receiving sequential FMT for SFCDI, in which we performed a longitudinal, integrative analysis of multiple host factors and intestinal microbiome changes. Stool samples were profiled for changes in gut microbiota and metabolites and blood samples for alterations in targeted epigenomic, metabonomic, glycomic, immune proteomic, immunophenotyping, immune functional assays, and T-cell receptor (TCR) repertoires, respectively. We characterised temporal trajectories in gut microbial and host immunometabolic data sets in three responders and one non-responder to sequential FMT. A total of 562 features were used for analysis, of which 78 features were identified, which differed between the responders and the non-responder. The observed dynamic phenotypic changes may potentially suggest immunosenescent signals in the non-responder and may help to underpin the mechanisms accompanying successful FMT, although our study is limited by a small sample size and significant heterogeneity in patient baseline characteristics. Our multi-omics integrative longitudinal analytical approach extends the knowledge regarding mechanisms of efficacy of FMT and highlights preliminary novel signatures, which should be validated in larger studies.Keywords
Funding Information
- University of Alberta Hospital Foundation (ZI418)
This publication has 80 references indexed in Scilit:
- Circulating Antibody and Memory B-Cell Responses to C. difficile Toxins A and B in Patients with C. difficile-Associated Diarrhoea, Inflammatory Bowel Disease and Cystic FibrosisPLOS ONE, 2013
- The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell HomeostasisScience, 2013
- An age-related numerical and functional deficit in CD19+CD24hiCD38hiB cells is associated with an increase in systemic autoimmunityAging Cell, 2013
- Systemic Dissemination of Clostridium difficile Toxins A and B Is Associated With Severe, Fatal Disease in Animal ModelsThe Journal of Infectious Diseases, 2011
- Health Care–AssociatedClostridium difficileInfection in Adults Admitted to Acute Care Hospitals in Canada: A Canadian Nosocomial Infection Surveillance Program StudyClinical Infectious Diseases, 2009
- Clostridium difficile--Associated Disease Treatment Response Depends on Definition of CureClinical Infectious Diseases, 2007
- Cytomegalovirus InfectionAnnals of the New York Academy of Sciences, 2007
- Defective responsiveness of CD5+ B1 cells to lipopolysaccharide in cytokine productionInnate Immunity, 2006
- Colonic IgA producing cells and macrophages are reduced in recurrent and non-recurrent Clostridium difficile associated diarrhoeaJournal of Clinical Pathology, 2004
- Health Care Costs and Mortality Associated with Nosocomial Diarrhea Due to Clostridium difficileClinical Infectious Diseases, 2002